Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment

NCT02035345 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02035345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02035345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2014
Completion date
June 30, 2016
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

platinum sensitive ovarian cancer, recurrent ovarian cancer